Heather A. Leitch

2.6k total citations
86 papers, 1.3k citations indexed

About

Heather A. Leitch is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Heather A. Leitch has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Genetics, 50 papers in Hematology and 22 papers in Oncology. Recurrent topics in Heather A. Leitch's work include Acute Myeloid Leukemia Research (39 papers), Hemoglobinopathies and Related Disorders (35 papers) and Lymphoma Diagnosis and Treatment (18 papers). Heather A. Leitch is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Hemoglobinopathies and Related Disorders (35 papers) and Lymphoma Diagnosis and Treatment (18 papers). Heather A. Leitch collaborates with scholars based in Canada, United States and Ireland. Heather A. Leitch's co-authors include Linda M. Vickars, Chantal S. Leger, Paul F. Galbraith, Anita Palepu, Joseph M. Connors, Randy D. Gascoyne, Khaled M. A. Ramadan, Lynda Foltz, Rena Buckstein and Maha A. Badawi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and ACS Nano.

In The Last Decade

Heather A. Leitch

82 papers receiving 1.3k citations

Peers

Countries citing papers authored by Heather A. Leitch

Since Specialization

Citations

This map shows the geographic impact of Heather A. Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather A. Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather A. Leitch more than expected).

Fields of papers citing papers by Heather A. Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather A. Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather A. Leitch. The network helps show where Heather A. Leitch may publish in the future.

Co-authorship network of co-authors of Heather A. Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of Heather A. Leitch. A scholar is included among the top collaborators of Heather A. Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather A. Leitch. Heather A. Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Iron Overload, Oxidative Stress, and Somatic Mutations in MDS: What Is the Association? 2025 ·European Journal Of Haematology ·Heather A. Leitch	1
2	Organisational factors associated with burnout among emergency and internal medicine physicians: a qualitative study 2025 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), L.C. Chow, Amy Salmon, Anita Palepu, Peter Dodek, Heather A. Leitch, Andrea Townson, Diane Lacaille, (unknown), (unknown), Nadia Khan	0
3	The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry 2023 ·Leukemia & lymphoma ·Rena Buckstein, (unknown), Karen Yee, Michelle Geddes, Heather A. Leitch, (unknown), Versha Banerji, Brian Leber, (unknown), Ève St‐Hilaire, (unknown), Thomas J. Nevill, Mary‐Margaret Keating, John M. Storring, (unknown), (unknown), Derek Tang, (unknown), Chris Cameron, (unknown)	3
4	Active transport nanochelators for the reduction of liver iron burden in iron overload 2022 ·Journal of Controlled Release ·Srinivas Abbina, Usama Abbasi, (unknown), Heather A. Leitch, Jayachandran N. Kizhakkedathu	9
5	Management of patients with lower-risk myelodysplastic syndromes 2022 ·Blood Cancer Journal ·Andrew M. Brunner, Heather A. Leitch, Arjan A. van de Loosdrecht, Nicolas Bonadies	12
6	Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae 2021 ·Critical Reviews in Oncology/Hematology ·(unknown), Heather A. Leitch	33
7	Delayed time from RBC transfusion dependence to first cardiac event in lower IPSS risk MDS patients receiving iron chelation therapy 2019 ·Leukemia Research ·(unknown), Heather A. Leitch	14
8	Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy 2018 ·Leukemia Research ·(unknown), (unknown), Heather A. Leitch	20
9	Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada 2017 ·Leukemia & lymphoma ·Lauren J. Lee, Cynthia L. Toze, (unknown), (unknown), Joseph M. Connors, Laurie H. Sehn, Hélène Bruyèrè, Heather A. Leitch, Khaled M. A. Ramadan, Alina S. Gerrie	7
10	Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit? 2017 ·Leukemia Research ·(unknown), Heather A. Leitch	10
11	Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies 2017 ·Critical Reviews in Oncology/Hematology ·Heather A. Leitch, Eitan Fibach, Eliezer A. Rachmilewitz	33
12	Design of Long Circulating Nontoxic Dendritic Polymers for the Removal of Iron in Vivo 2013 ·ACS Nano ·Muhammad Imran ul‐haq, (unknown), Benjamin Lai, Rajesh A. Shenoi, Sonja Horte, Iren Constantinescu, Heather A. Leitch, Jayachandran N. Kizhakkedathu	74
13	Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis 2012 ·Leukemia Research ·Heather A. Leitch, Christopher T. Chan, Chantal S. Leger, Lynda Foltz, Khaled M. A. Ramadan, Linda M. Vickars	27
14	Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma 2012 ·Leukemia & lymphoma ·(unknown), Matthew C. Cheung, Lisa K. Hicks, (unknown), Joan Montaner, Viviane D. Lima, Marianne Harris, Heather A. Leitch	21
15	Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case report 2011 ·Journal of Medical Case Reports ·Mayur Brahmania, (unknown), Heather A. Leitch	23
16	Treatment of relapsed and refractory myeloma 2008 ·Leukemia & lymphoma ·Donna Reece, Heather A. Leitch, Harold Atkins, Michael Voralia, (unknown), Richard LeBlanc, Andrew R. Belch, Darrell White, Michael J. Kovacs	12
17	Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis 2007 ·Leukemia & lymphoma ·(unknown), (unknown), Chantal S. Leger, (unknown), Linda M. Vickars, Paul F. Galbraith, Charles Li, Heather A. Leitch	37
18	Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma 2007 ·Annals of Hematology ·Matthew C. Cheung, Kevin Imrie, Heather A. Leitch, Laura Park‐Wyllie, Rena Buckstein, Tony Antoniou, Mona Loutfy	3
19	Rapid determination of Epstein–Barr virus latent or lytic infection in single human cells using in situ hybridization 2004 ·Modern Pathology ·(unknown), Renate Panzer‐Grümayer, Susanna Fischer, Heather A. Leitch, Douglas E. Horsman, Thomas Lion, Helmut Gadner, Peter F. Ambros, Valia S. Lestou	15
20	Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis 2004 ·Annals of Oncology ·Joy Mangel, Heather A. Leitch, Joseph M. Connors, Rena Buckstein, Kevin Imrie, David Spaner, Michael Crump, Nancy Pennell, (unknown), Neil L. Berinstein	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact